about
CD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureyleneSerum TNF-alpha in psoriasis after treatment with propylthiouracil, an antithyroid thioureyleneThe antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cellsHLA-DQA1 and DQB1 alleles are associated with genetic susceptibility to psoriasis vulgaris in Chinese HanSkin innate immune system in psoriasis: friend or foe?Creation of psoriatic plaques: the ultimate tumor suppressor pathway. A new model for an ancient T-cell-mediated skin disease. Viewpoint.Severe combined immunodeficiency mouse-human skin chimeras: a unique animal model for the study of psoriasis and cutaneous inflammation.The role of CD30 in atopic disease.Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.Overview of psoriasis.Computational approach to identify enzymes that are potential therapeutic candidates for psoriasis.A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice.The role of T cells in psoriasis.Genetic basis of psoriasis vulgaris and its pharmacogenetic potential.The immunological basis of psoriasis.Aberrant signalling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis.Do eating disorders accompany metabolic syndrome in psoriasis patients? Results of a preliminary studyImmunopathogenic mechanisms in psoriasis.Suprabasal overexpression of the hsRPB7 gene in psoriatic epidermis as identified by a reverse transcriptase-polymerase chain reaction differential display model comparing psoriasis plaque tissue with peritonsillar mucosaInjection of pre-psoriatic skin with CD4+ T cells induces psoriasisBiological therapies in the systemic management of psoriasis: International Consensus Conference.Psoriasis: emerging therapeutic strategies.Ustekinumab in the therapy of chronic plaque psoriasis.Genomic-scale analysis of psoriatic skin reveals differentially expressed insulin-like growth factor-binding protein-7 after phototherapy.Inhibition of keratin 17 expression with antisense and RNAi strategies: exploring novel therapy for psoriasis.Generalized pustular psoriasis complicated by acute respiratory distress syndrome.Cyclin D1, B and A expression and cell turnover in psoriatic skin lesions before and after cyclosporin treatment.Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation.Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early-onset, psoriasis-like skin pathology: expression of amphiregulin in the basal epidermis is also associated with synovitis.Psoriasiform dermatitis susceptibility in Itgb2(tm1Bay) PL/J mice requires low-level CD18 expression and at least two additional loci for progression to severe disease.Studies of synthetic chalcone derivatives as potential inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and pro-inflammatory cytokines.Preferential expression of alphaEbeta7 integrin (CD103) on CD8+ T cells in the psoriatic epidermis: regulation by interleukins 4 and 12 and transforming growth factor-beta.The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance.In vivo response of GsdmA3Dfl/+ mice to topically applied anti-psoriatic agents: effects on epidermal thickness, as determined by optical coherence tomography and H&E staining.Prolactin level is significantly elevated in lesional skin of patients with psoriasis.Regulation of vascular endothelial growth factor expression by insulin-like growth factor-II in human keratinocytes, differential involvement of mitogen-activated protein kinases and feedback inhibition of protein kinase C.Neurofibromatosis type 1 tumour suppressor gene expression is deficient in psoriatic skin in vivo and in vitro: a potential link to increased Ras activity.In vitro screening for putative psoriasis-specific antigens among wheat proteins and peptides.Targeting T-cell subsets to achieve remission.CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis.
P2860
Q24791832-A9FEA711-68C6-40DE-8010-3527FD050B37Q24803476-65D0C3DE-5964-4FB2-8263-0DF736D0881AQ28203312-9CC7478E-5434-4821-BBF9-F6C1D88C44DCQ28249252-F3A47153-20AD-436F-9252-1E64E3B535EEQ33764350-52720753-2738-4E1F-8641-9E37419C8594Q34135765-58B93FB1-90D3-49AE-9A8F-162D759440FAQ34255262-09825C05-2479-4E3F-8598-842445252DABQ34291177-245BA06F-FBD2-46B5-BB6E-258853BB4B30Q34327203-AC5EC83E-1EB3-4E91-9C5E-4392DB2B425BQ34551058-BE1006E2-7B67-4058-8F9B-6A7676014327Q35062126-AD56AA15-362B-4787-86FB-08193CBA22A0Q35083718-7D3FDD53-DFA2-445B-8CC8-68FBB33CFD6AQ35110104-44D4880A-2679-410F-A8F3-AA0DA39AE5DFQ35116099-99449D44-419C-491B-A5FF-0E63CED923B5Q35149415-C49B6F50-16F2-4388-BD00-342B0829F3E2Q35203839-8B9C6B55-62A1-44FD-97D2-7DD704321B32Q35212941-624DE5D5-9153-45CA-8ECF-E8683800C550Q35608884-49132680-9498-4A89-84F8-F7FA2C355502Q35746233-2D30000A-558D-49B5-94F4-5D32E577616DQ35787223-781AE854-7831-4E48-9147-D70E8E83B8E9Q35841615-A120ABF0-B981-441E-8A9C-F6E1837AB1A8Q36028220-8F5B1ADA-3A56-49DE-8663-D0CDAFEF2B47Q37303190-4FFD794E-4859-4F69-BB88-7B73A5AF5BE4Q38305758-6AAEA6F7-4A87-4974-B6D1-030FE1686AB3Q39585242-2686F602-4EA1-4FC4-B5AF-6E9134D1EB16Q40539204-F47B9B88-14CC-43B9-9FEA-57F0B79BC102Q40739734-7D07A860-A017-474A-85EC-9BD417E95173Q41893585-88C84352-6A43-4A33-AB4E-F14311069020Q42462805-559937CB-BBAB-4805-80A3-E526A90EBFC2Q42792412-862C4D01-B16C-484E-B752-CF679365CF9BQ42910608-FBEFE81F-06E7-46E3-B5FE-B91734D01824Q44230034-51FC2A1D-CFF9-4110-8E75-1102ACCBD16DQ45792913-950E39FF-CFB5-41E0-9537-D3FF03C3D474Q45812015-42498423-0FF0-4792-A835-796DF542C44CQ46380508-E81353E4-74DA-4ADE-85D9-166CB87AD6AFQ46401417-3EA1276E-D5FB-441F-A497-F3E69009FCBAQ48011726-9FCC4A1E-A685-401F-9067-9180C82721BCQ51414778-C29309D4-9961-4579-A66D-CFCCA06A524DQ52007377-D3650FA9-1406-4D3F-BE42-411FB8A54ABEQ52014063-CA9FDF3E-B7D9-44E8-8376-D35698EF3A2C
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The immunologic and genetic basis of psoriasis.
@ast
The immunologic and genetic basis of psoriasis.
@en
type
label
The immunologic and genetic basis of psoriasis.
@ast
The immunologic and genetic basis of psoriasis.
@en
prefLabel
The immunologic and genetic basis of psoriasis.
@ast
The immunologic and genetic basis of psoriasis.
@en
P1433
P1476
The immunologic and genetic basis of psoriasis.
@en
P2093
Nickoloff BJ
P304
P356
10.1001/ARCHDERM.135.9.1104
P577
1999-09-01T00:00:00Z